They all had severe disease and a high treatment burden with an average of 10 injections with Eylea (aflibercept), a widely-used VEGF inhibitor sold by Bayer and Regeneron, in the last 12 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback